Sanofi’s Bundled Pediatric Vaccine Contracts Challenged In Antitrust Suit
A class action complaint alleges that Sanofi’s meningococcal vaccine pricing contracts deter physician buying groups from purchasing Novartis’s competing vaccine. The American Antitrust Institute seeks FTC review of these bundled discounts.
You may also be interested in...
The apparently first-ever FDA press release for an advertising warning letter underscores importance of opioid issues – and the agency’s changing approach to media relations in general. FDA objects to Alkermes journal ad that excludes risk information about its opioid dependence treatment drug.